Carbonic anhydrase IX expression in prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 13, Issue 2, 2010, Pages 178-181

  Smyth, L G ^a   O'Hurley, G ^b   O'Grady, A ^b   Fitzpatrick, J M ^b   Kay, E ^b   Watson, R W G ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Carbonic anhydrase IX; Hypoxia; PH

Indexed keywords

CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR 1;

ARTICLE; GLEASON SCORE; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PH; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CELL HYPOXIA; HUMANS; MALE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77952554010     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2009.58     Document Type: Article

References (32)

1. Vaupel P. Hypoxia in breast cancer: Pathogenesis, characterisation and biological/therapeutic implications. Wiener Medizinische Wochenschrift 2002;152, pp 334-342.
2. Marginol L, Coffey M, Lawlor M, Hollywood D. Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treat Rev 2008;34, pp 313-327.
3. Hoeckel M, Vaupel P. Biological consequences of tumour hypoxia. Semin Oncol 2001;28, pp 26-41.
4. Harris A. Hypoxia a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2, pp 38-47.
5. Vergis R, Corbishley CM, Norman AR, Bartlett J, Jhavar S, Borre M et al. Intrinsic markers of hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncol 2008;9, pp 342-351.
6. Sherwood B, Colquhoun AJ, Richardson D, Bowman KJ, O'Byrne KJ, Kockelbergh RC et al. Carbonic anhydrase IX expression and outcome after radiotherapy for muscleinvasive bladder cancer. Clin Oncol (R Coll Radiol) 2007;19, pp 777-783.
7. Swinson D, Jones JL, Richardson D. Carbonic anhydrase IX expression, a novel surrogate marker of tumour hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 2003;21, pp 473-482.
8. Bui M, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 2003; pp 802-811.
9. Schrijvers M, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L et al. Overexpression of intrinsic hypoxic markers HIF 1 alpha and CA IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2008;72, pp 161-169.
10. Sennoune S, Luo D, Martinez-Zaguilam R. Plasma-lemmal vacuolar-type H+-ATPase in cancer biology. Cell Biochem Biophys 2004; pp 185-206.
11. Nishi T, Forgac M. The vacuolar (H) -ATPases-nature's most versatile proton pumps. Nature Rev Mol Cell Biol 2002; pp 94-103.
12. Sennoune S, Bakunts K, Martinez GM. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell 2004;286, pp 1443-1452.
13. Potter C, Harris AL. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle 2004; pp 164-167.
14. Saarnio J, Parkkila S, Parkkila AK. Immunohistochemistry of carbonic anhydrase isozyme in human gut reveals polarised expression in the epithelial cells with the highest proliferative capacity. Cytochem 1998;46, pp 497-504.
15. Zavada J, Zadadova Z, Pastorek J, Biesova Z, Jezek J, Velek J. Human tumour-associated cell adhesion protein MN/CA IX: identification of M 75 epitope and of the region mediating cell adhesion. Br J Cancer 2000;82, pp 1808-1813.
16. Svastova E, Zilka N, Zat'ovicova M, Gibadulinova A, Ciampor F, Pastorek J. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCk cells via interaction with beta-catenin. Exp Cell Res 2003;290, pp 332-345.
17. Robertson N, Potter C, Harris AL. Role of carbonic anhydrase IX in human tumour cell growth, survival and invasion. Cancer Res 2004;64, pp 6160-6165.
18. Parkkila S. Significance of pH regulation and carbonic anhydrases in tumour progression and implications for diagnostic and therapeutic approaches. BJU Int 2008; (Supp 4): pp 16-21.
19. Winum J, Innocenti A, Scozzafava A, Montero JL, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids. Bioorg Med Chem 2009;17, pp 3649-3652.
20. Klatte T, Belldegrun AS, Pantuck AJ. The role of carbonic anhydrase IX as a molecular maker for transitional cell carcinoma of the bladder. BJU Int 2008;101(Supp 4): pp 45-48.
21. Belldegrun A, Bevan P. Carbonic anhydrase IX: role in the diagnosis and cancer therapy. Introduction. BJU Int 2008;101(Supp 4): pp 1.
22. Said J. Biomarker discovery in urogenital cancer. Biomarkers 2005;10, pp 83-86.
23. Rasheed S, Harris AL, Tekkis PP, Silver A, McDonald PJ, Talbot IC et al. Assessment of microvessel denisty and carbonic anhydrase-9 CA-9 expression in rectal cancer. Pathol Res Pract 2009;205, pp 1-9.
24. Parker C, Milosevic M, Toi A, Sweet J, Panzarella T, Bristow R et al. Polargraphic electrode study of tumour oxygenation in clinically localised prostate cancer. Int J Radiat Oncol Biol Phys 2004;58, pp 750-757.
25. Lekas A, Lazaris AC, Deliveliotis C, Chrisofos M, Zoubouli C, Lapas D et al. The expression of hypoxia-inducible factor-1alpha and angiogenesis in hyperplastic and malignant prostate tissue. Anticancer 2006;26, pp 2989-2993.
26. Forgac M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nature Rev/Mol Cell Biol 2007;8, pp 917-929.
27. Jefferies K, Cipriano DJ, Forgac M. Function, structure and regulation of the vacuolar (H) - ATPases. Arch Biochem and Biophysics 2008;476, pp 33-42.
28. Herak-Kramberger C, Breton S, Brown D, Kraus O, Sabolic I. Distribution of the vacuolar H+ ATPase along the rat and human male reproductive tract. Biol Reprod 2001;64, pp 1699-1707.
29. Stock C, Schwab A. Protons make tumour cells move like clockwork. Plfugers Arch 2009.
30. Halestrap A, Meredith D. The SLC 16 gene family fafrom monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Plfugers Arch 2004;447, pp 619-628.
31. Halestrap A, Price NT. The proton linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 1999;343, pp 281-299.
32. Ord J, Streeter EH, Roberts IS, Cranston D, Harris AL. Comparison of hypoxia in vitro with in vivo gene expression in human bladder cancer. Br J Cancer 2005;93, pp 346-354.